Long-Lived Families Share a Rare Gene Variant That Curbs Inflammation and Extends Healthspan
Researchers found 12 rare genetic variants in long-lived families, including one in the CGAS gene that may reduce chronic inflammation and delay disease.
Summary
Scientists studying entire long-lived families have identified 12 rare genetic variants that may help people stay disease-free far longer than average. The most compelling finding centers on the CGAS gene, which regulates inflammation. People in certain long-lived families appear to carry only one active copy of this gene, reducing chronic inflammatory signaling while still protecting against infection. This matters because the same families showed that middle-aged members developed cardiometabolic diseases an average of 13 years later than peers from shorter-lived families. By studying family groups rather than individuals, researchers could filter out lifestyle and environmental noise, zeroing in on inherited biological mechanisms that genuinely extend healthspan — the years lived free from chronic disease and cognitive decline.
Detailed Summary
Most of us accept that aging brings disease, but some families consistently escape serious illness well into old age. Understanding why could reshape how medicine approaches aging prevention. New research presented at the European Society of Human Genetics annual conference suggests the answer may lie in rare inherited genetic variants that quietly buffer the body against the wear and tear of time.
Researchers at Leiden University Medical Center analyzed the genomes of 212 groups of long-lived siblings from the Leiden Longevity Study. By focusing on family clusters rather than lone centenarians, they could separate inherited biological protection from lifestyle or environmental luck. The approach narrowed the genomic search from roughly 20,000 genes down to just 350, ultimately revealing 12 rare protein-altering variants potentially linked to extended healthspan.
The most striking find involved the CGAS gene — cyclic GMP-AMP synthase — a known aging-related gene that triggers inflammation when damaged or out-of-place DNA is detected inside cells. Members of two long-lived families appeared to carry only one functional copy of CGAS rather than two, suggesting a naturally dampened inflammatory response. The researchers believe this partial reduction in CGAS activity may limit chronic low-grade inflammation, a key driver of age-related diseases, while preserving enough immune function to fight infections and repair cellular damage.
This matters clinically because prior work from the same team found that middle-aged offspring of long-lived parents developed cardiometabolic diseases an average of 13 years later than partners from average-longevity families — a striking, heritable healthspan advantage passed across generations.
Caveats remain important. The CGAS variant was identified in only two families, and results have not yet been peer-reviewed or published in a full journal article. Larger replication studies are needed before any clinical translation is possible. Still, CGAS represents a credible, biologically plausible target for future anti-inflammatory longevity therapies.
Key Findings
- Offspring of long-lived parents developed cardiometabolic diseases an average of 13 years later than peers.
- Analysis of 212 long-lived family groups identified 12 rare protein-altering genetic variants linked to healthspan.
- A variant in the CGAS gene reduces inflammatory signaling and appeared in multiple long-lived families.
- Carrying one rather than two active CGAS copies may limit chronic inflammation while preserving immune defense.
- Family-based genomic studies outperform individual-focused studies in isolating inherited longevity mechanisms.
Methodology
This is a conference news report summarizing preliminary findings presented at the European Society of Human Genetics 2026 annual meeting; the research has not yet appeared in a peer-reviewed journal. The source organization is credible and the underlying study draws on the well-established Leiden Longevity Study cohort. Evidence is observational and genomic, based on 212 long-lived sibship groups.
Study Limitations
Findings are preliminary, presented at conference and not yet peer-reviewed or published in full. The CGAS variant was found in only two families, making replication in larger cohorts essential before drawing firm conclusions. Lifestyle, diet, and socioeconomic factors shared within families could confound genetic interpretations despite the study design attempting to control for them.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.